Dynarop Products SRL
Dynarop Products reported total assets of €1.19m at the end of the 2024 financial year (annual accounts filed with the NBB on 31 Oct 2025).
The score of Dynarop Products shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +56 % Total assets +5 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dynarop Products's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 31 Oct 2025
- Year ended 31 Dec 2023filed on 14 Nov 2024
- Year ended 31 Dec 2022filed on 30 Oct 2023
- Year ended 31 Dec 2021filed on 01 Dec 2022
- Year ended 31 Dec 2020filed on 30 Nov 2021
Dynarop Products's financial analysis
- Solvency24.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dynarop Products
Dynarop Products's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0894.533.010
- VAT number
- BE0894533010
- Peppol
- Registered · 0208:0894533010 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Dec 2007
- Registered office
- 7711 Mouscron
- Latest accounts
- 2024 · filed on 31 Oct 2025
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Dynarop Products (SRL) has been based in Mouscron since 2007, active in: retail sale of pharmaceutical products. For 2024, it reports a net profit of 34,393 € and equity of 286,534 €; its revenue is not published. Its solvency stands at 24.1%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dynarop Products
Companies in the same business, of comparable size and area, outside its group.
- Jeandarme Manufacture of pharmaceutical preparations Sint-Truiden · balance sheet €1.60m
- Codema Pharma Retail sale of pharmaceutical products Brussels · balance sheet 375,959 €
- Apotheek Leleu Retail sale of pharmaceutical products Menen · balance sheet 908,279 €
- Pharmacie Haegeman Retail sale of pharmaceutical products Châtelet · balance sheet €1.22m
- Pharma Werbomont Retail sale of pharmaceutical products Ferrières · balance sheet €1.35m
- Bontemps Invest Retail sale of pharmaceutical products Brussels · balance sheet €1.45m
- Sego Pharma Retail sale of pharmaceutical products Dessel · balance sheet 939,072 €
- Apotheke Mertens Retail sale of pharmaceutical products Eupen · balance sheet 668,099 €
Frequently asked questions about Dynarop Products
What is the revenue of Dynarop Products?
Dynarop Products files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Dynarop Products?
In Belgium, the VAT number is the company number prefixed with BE: BE0894533010 for Dynarop Products, if the company is VAT-registered. Its company number (CBE) is 0894.533.010.
Where is the registered office of Dynarop Products?
According to the CBE register, the registered office of Dynarop Products is in 7711 Mouscron.
What is the equity of Dynarop Products?
At the close of the 2024 financial year, the equity of Dynarop Products amounts to 286,534 €, a solvency of 24.1% of total assets.
Who manages Dynarop Products?
The register lists 2 active mandates at Dynarop Products. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dynarop Products
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →